본문 바로가기

Prevalence and Clinical Characteristics of Severe Asthma With Fungal Sensitization in Korea

문서 유형
연구출판물 · 학술지 논문
등재
KCISCIEScopus
저널 순위
JCR Q2Scopus Q1KCI Q1
저널
ALLERGY ASTHMA & IMMUNOLOGY RESEARCH17(4) · pp.447 · 2025
피인용
Web of Science 2Scopus 2KCI 0
FWCI (Scopus)
0.28
JCR IF
JCR 2024 4.3
ISSN
2092-7355

저자

  1. Rhyou, Hyo-In제1저자Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med, 875 Haeun Daero, Busan 48108, South Korea
  2. Kim, Tae-BumUniv Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea
  3. Yoon, Sun-YoungChungnam Natl Univ, Sejong Hosp, Dept Allergy, Sejong, South Korea
  4. Kwon, Jae-WooKangwon Natl Univ, Sch Med, Dept Internal Med, Chunchon, South Korea
  5. 박혜경Pusan Natl Univ, Sch Med, Dept Internal Med, Busan, South Korea
  6. Kim, Sung-RyeolYonsei Univ, Yongin Severance Hosp, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med,Coll Med, Seoul, South Korea
  7. Nam, Young-HeeDong A Univ, Sch Med, Dept Internal Med, Busan, South Korea
  8. Kim, Joo-HeeHallym Univ, Coll Med, Dept Internal Med, Anyang, South Korea
  9. Cho, Young-JooEwha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea
  10. 윤호주Hanyang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
  11. Shin, Yoo SeobAjou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea
  12. Jung, Jae-WooChung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
  13. Lee, TaehoonUniv Ulsan, Coll Med, Ulsan Univ Hosp, Dept Internal Med, Ulsan, South Korea
  14. Chang, Yoon-SeokSeoul Natl Univ, Bundang Hosp, Dept Internal Med, Seongnam, South Korea
  15. Cho, Sang-HeonSeoul Natl Univ Hosp, Dept Internal Med, Seoul, South Korea
  16. 이승은Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Yangsan, South Korea
  17. Lee, Byung-JaeSungkyunkwan Univ, Samsung Med Ctr, Dept Med, Div Allergy,Coll Med, Seoul, South Korea
  18. Lee, Hwa YoungCatholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Allergy, Seoul, South Korea
  19. Jin, Hyun JungYeungnam Univ, Coll Med, Dept Internal Med, Daegu, South Korea
  20. Park, So-YoungChung Ang Univ, Coll Med, Dept Internal Med, Seoul, South Korea
  21. Sohn, Kyoung-HeeKyung Hee Univ, Sch Med, Dept Internal Med, Div Pulmonol & Allergy, Seoul, South Korea
  22. Kim, Byung KeunKorea Univ, Coll Med, Dept Internal Med, Div Pulmonol Allergy & Crit Care Med, Seoul, South Korea
  23. Lee, YoungsooAjou Univ, Sch Med, Dept Allergy & Clin Immunol, Suwon, South Korea
  24. Song, Woo-JungUniv Ulsan, Coll Med, Asan Med Ctr, Dept Allergy & Clin Immunol, Seoul, South Korea
  25. Kim, Sang-Heon교신저자Hanyang Univ, Hanyang Univ Hosp, Coll Med, Dept Internal Med, 222 Wangsimni Ro, Seoul 04763, South Korea
  26. Park, Chan Sun교신저자Inje Univ, Haeundae Paik Hosp, Coll Med, Dept Internal Med, 875 Haeun Daero, Busan 48108, South Korea

초록

Purpose: Severe asthma with fungal sensitization (SAFS) is associated with life-threatening exacerbation and severe airflow limitation. We aimed to investigate the prevalence of fungal sensitization in asthma and clinical characteristics of SAFS. Methods: This study analyzed data from the Cohort for Reality and Evolution of Adult Asthma in Korea and the Korean Severe Asthma Registry cohorts. Study subjects were classified based on fungal sensitization and asthma severity. Clinical characteristics of patients with severe asthma were compared according to fungal sensitization status. Results: The rate of skin test positivity to fungi was 14.1% and 7.1% in severe asthma (n = 270) and non-severe asthma (n = 2,605). Patients with SAFS were diagnosed with asthma earlier than those with severe asthma without fungal sensitization (SANFS) (P = 0.019), and had a lower body mass index compared to the SANFS group (P = 0.044). Factional exhaled nitric oxide levels and sputum eosinophilia/neutrophilia showed significant differences between the SAFS and SANFS groups (all P < 0.05). Patients with SAFS were more frequently treated with biologics (36.8% vs. 24.6%, P = 0.116) than those with SANFS. Multivariate analysis revealed that early diagnosed asthma was significantly associated with SAFS. Conclusions: The prevalence of fungal sensitization in severe asthma is approximately twice as high as in non-severe asthma. Early diagnosed asthma may be a risk factor for SAFS, and patients with SAFS face a greater burden of additional treatment compared to those with SANFS. SAFS has a distinct airway inflammation profile that differentiates it from SANFS.

키워드

Asthmafungiimmunologic sensitizationeosinophilsneutrophilsbiologicsCANDIDA-ALBICANSRANDOMIZED-TRIALIMMUNITYITRACONAZOLELUNGSCELLSRISKMOLD

식별자

Scopus EID
2-s2.0-105014146556
WoS UID
001542174300005
KCI
ART003230471